Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models-Reference-Cited by-同舟云学术

Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models

Published:2018-04-06 Issue:27 Volume:37 Page:3686-3697
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Crossland Denise L.,Denning Warren L.,Ang Sonny,Olivares Simon,Mi Tiejuan,Switzer Kirsten,Singh Harjeet,Huls Helen,Gold Kate S.,Glisson Bonnie S.,Cooper Laurence J.,Heymach John V.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-018-0187-2.pdf

Reference36 articles.

1. Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med. 2015;373:23–34.

2. Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, et al. Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med. 2015;372:2018–28.

3. Page DB, Postow MA, Callahan MK, Allison JP, Wolchok JD. Immune modulation in cancer with antibodies. Annu Rev Med. 2014;65:185–202.

4. Ott PA, Elez E, Hiret S, Kim DW, Morosky A, Saraf S, et al. Pembrolizumab in patients with extensive-stage small cell lung cancer: updated survival results from KEYNOTE-028 2016. J Clin Oncol. 2017;35:3823–9.

5. Taylor M, Antonia S, Bendell J, Calvo E, Jäger D, de Braud F, et al. Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032. J Immunotherapy Cancer. 2015;3:P376.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future of Clinical Trials and Application of Precision Medicine;Pediatric Oncology;2024

2. YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities;2023-12-20

3. A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma;2023-12-08

4. Novel Therapeutic Options for Small Cell Lung Cancer;Current Oncology Reports;2023-10-23

5. Virus-associated neuroendocrine cancers: Pathogenesis and current therapeutics;Pathology - Research and Practice;2023-08